Answers are grounded in this paper and cite their sources.
Sarcopenia is an age‐related syndrome characterized by progressive declines in muscle mass, strength, and physical performance. To investigate the shared genetic architecture of quantitative traits relevant to sarcopenia, we integrated genome‐wide association study (GWAS) summary statistics for appendicular lean mass, hand grip strength, and walking pace from the UK Biobank. Significant genetic correlations among these traits supported multi‐trait integration, resulting in an integrated GWAS termed mtMuscleAging. A total of 405 associated loci were identified, including 78 loci with enhanced significance and 33 loci that did not reach genome‐wide significance in any individual trait GWAS. Fine‐mapping prioritized 538 candidate variants, while integrative post‐GWAS analyses identified prioritized genes and highlighted conserved coding regions and biological pathways related to muscle, heart, pancreas, fibroblasts, and aging. Single‐cell and single‐nucleus transcriptomic analyses further contextualized these genetic findings in aging skeletal muscle and identified alterations in midkine and pleiotrophin signaling and intercellular communication. Phenome‐wide association analyses identified genetic relationships between mtMuscleAging and multiple health phenotypes, including cardiovascular disorders. Machine‐learning analyses based on prioritized genes captured age‐associated skeletal muscle expression patterns, while drug repurposing analyses nominated candidate compounds for further experimental evaluation. Collectively, our findings characterize shared genetic variation across sarcopenia‐related traits and provide loci, genes, cellular contexts, and candidate compounds relevant to muscle aging.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: